LRMR

Larimar Therapeutics, Inc. · Healthcare · Market cap $401.5M

Insiders bought $167K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Jul 8, 2026

Insider Buying

$25.7M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Latest filing

Jul 8, 2026

Hamilton Thomas Edward

Larimar Therapeutics, Inc. (LRMR) has 9 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.

Inside the rolling window, 4 insiders at Larimar Therapeutics, Inc. reported 5 open-market purchases totaling $25.7M and no open-market sales. Insiders have net bought $25.7M over the trailing 6 months. The largest single insider purchase in this window was $25.0M by Director, 10% Owner Flynn James E on Feb 27, 2026. The most recent open-market filing is a purchase of 50,000 shares by Director Hamilton Thomas Edward, dated Jul 6, 2026, worth $167K.

  • Industry:Biotechnology
  • CEO:Carole S. Ben-Maimon
  • Employees:71
  • HQ:Bala Cynwyd, PA, US
  • IPO:2014-06-19
Source
Hamilton Thomas EdwardFirst in 4 months
Purchase$167KJul 8SEC ↗
Flynn James EFirst in 3 months
Purchase$25.0MMar 2SEC ↗
THOMAS FRANK EFirst filing
Purchase$25KMar 2SEC ↗
SHERMAN JEFFREY WFirst filing
Purchase$25KMar 2SEC ↗
Purchase$500KMar 2SEC ↗
Showing 1–5 of 5
1 / 1

Frequently asked questions

How many SEC Form 4 insider filings does LRMR have?

Larimar Therapeutics, Inc. (LRMR) has 9 SEC Form 4 filings (12 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.

When was the most recent SEC Form 4 filing for LRMR?

The most recent Form 4 filing for LRMR on Tracefour is dated Jul 8, 2026.

What is the net insider flow at LRMR over the last 6 months?

Over the trailing 180 days, insiders at LRMR have net bought $25.7M based on SEC Form 4 disclosures.

What was the largest insider purchase at LRMR?

The largest single insider open-market purchase at LRMR in the rolling window was $25.0M by Director, 10% Owner Flynn James E on 2026-02-27.

What is the total insider buy and sell value at LRMR in the current window?

Inside the rolling window, insiders at LRMR bought $25.7M and sold $0 based on SEC Form 4 filings.

Can I get alerts for LRMR insider trading?

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Larimar Therapeutics, Inc. (LRMR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

Related companies

Larimar Therapeutics, Inc. is in the Healthcare sector.